Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

BioNTech SE (BNTX)

NASDAQ
Symbol
Exchange
Currency
BNTXNASDAQUSD
BNTXNBIVAMXN
22UAyXetraEUR
22UAyFrankfurtEUR
22UAyTradeGateEUR
BNTXViennaEUR
Currency in USD
Disclaimer
86.40
+0.06(+0.07%)
Closed
After Hours
86.06-0.34(-0.39%)

BNTX Comments

avrg 287
added 5
so far all the daily gaps have been filling, so maybe some hope for bulls with the 195 daily gap https://invst.ly/x5ee9
finally getting my short work
Maybe after this news it might go up --- WHO says no evidence healthy children, adolescents need COVID-19 boosters ----
Nobody cares about children good news (since many months even when FDA agree) . The only thing investors want to know is if there will be new orders beyond 2022.
Or at least maybe the new omicron vaccine in March.
there are no new orders. guidance for 2022 was given by BNTX and it was at the lower end. Europe and US has ordered 5x the population. nobody else will order, close to expired vaccine will be donated to COVAX, that's it.
Dan G. Fine...you want to be the Bullish voice in support of BNTX, go right ahead. We all look forward to your words of wisdom.
🤣🤣🤣
why such negative performance today?
pure garbage 🗑😒
YOu have to have a stomach to buy and reward will come!
Or it is the same history with the cannabis sector two years ago .....
150$
possible but no logic in
how low can it go
worst can go to 100 euro. but that should be crazy.. i think lowest can go is 140 euro. so i think good time to
enter
When its low enough, pfizer will buy
As I said yesterday, clearly bearish trend lol (especially after what Albert Bourla said to BFM)
one veey good thing. rob is in silence. now the price can finaly raise next days
looks like a bump and run case, although the lt uptrend around 140 currently looks solid if it ever tests that https://invst.ly/x59us
bought some
Around 160$ maybe make sense … but not aure it’s over this one
What is there? P/E will be 4 not 5? :)
Rob roo where r u? Whatr u gonna comment?
Dan G. has stepped in...
Momentum is clearly against this now - we are trading “end covid”. But what does endemic state mean? It’ll probably mean that people will get a yearly vaccine for many years to come. Where biontech will probably continue to be a big supplier. Then - all this cash they are making plus top knowledge of mRNA will lead to new and other medications. CEO said he expetcs 30% of ALL medications in 10 years to be mRNA based. 30!!!!! Even if this should prove optimistic (and his predictions were pretty good so far) this could make Biontech long term a MASSIVE player. Not to mention the covid vacc was just a by product - they are actually set out to beat cancer. In brief: momentum very negative here - but mid to long term good chances of strong upside - worth keeping and adding to it if it comes off a lot more.
I think this week it's going to go down even further ! Pfizer CEO ruined it even more on top of fourth dose inefficacy against omicron. am thinking of completely offloading the shares with losses. any suggestions ?
wait a little longer. much lower can t go..
‼️‼️‼️Jan.17: Pfizer CEO Albert Bourla, on French TV station BFM TV today, has said that while COVID-19 will CONTINUE to circulate for MANY YEARS to come, this current wave should be the last to have to lead to restrictions.
Today the pdf of pfizer (albert bourla) announced to BFM TV that it will likely be the last wave and it would become endemic in the future .  Clearly a bearish trend in the months to come for vaccine stocks
pdg*
Wrong information, Mr. Kaitani. Pfizer CEO Albert Bourla said in fact: "It may be the last wave with restrictions" BUT "the virus will be here for years". Restrictions can ONLY be lifted when there is sufficient immunity within a population. Periodic vaccination will be necessary to reach and keep that status of freedom due to the virus' dangerous nature to frequently create new (escape) variants. Please quote carefully in order to avoid misinformation. Thank you.
half of Europe reached immunity by getting infected....so no need to vaccine, in fact doctors do not recommend to get vaccine after infection...simpler and cheaper
🔥🔥🔥Source AP- By LAURA UNGAR Jan.15, 2022: Expect more worrisome variants after omicron; Experts say the virus WON'T become ENDEMIC like the flu as long as global vaccination rates are so low. New variants are INEVITABLE, said Louis Mansky, director of the Institute for Molecular Virology at the University of Minnesota. Coronavirus will be around for years to come!!!
P/E Ratio5.99 means this company will never grow, if you believe that?, sell.I believe it will.
BIG Buy Time!!!
shut up please,make us an favour,you are boring. you keep say that since the price was 300$..
Be patient...great news coming on the form of Omicron booster and release of another vaccine in the pipeline. Look at NVAX share price with nothing to offer. 🚀🚀🚀🚀🚀🚀🚀
yes,but the market cap is only 8 bilions at novavax. so 5 times cheaper..
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.